
Liver fibrosis and stem cell therapy
1. Laboratory of Drug Design and Molecular Pharmacology, School of Pharmaceutical Science, Jiangnan University, Wuxi 214122, China; 2. Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou 215006, China; 3. Cyrus Tang Hematology Center and Ministry of Education Engineering Center of Hematological Disease, Soochow University, Suzhou 215123, China
Online published: 2017-03-30
Supported by
National High-tech R&D Program of China, 863 Program, 2014AA021003
Liver fibrosis is a common chronic liver disease, which is a stress response process of liver cells affected by one or more pathogenies for long term or repeatedly. During the fibrosis process, massive accumulated extracellular matrix can form scar tissue, which results in liver dysfunction or failure and seriously endangers the health of people. According to many independent reports, stem cell therapy can facilitate the alleviation of liver fibrosis. During the stem cell therapy, stem cells migrate to the injury site of liver and alleviate the liver fibrosis by improving the microenvironment of the scar area via paracrine way. This article reviews the formation, treatment, and stem cell therapy of liver fibrosis.
Key words: liver fibrosis; stem cell; hepatocyte growth factor; paracrine
XU Dong-sheng , WAN Ai-ni , CHEN Yun , HE Yang , YANG Jian-feng , JIN Jian . Liver fibrosis and stem cell therapy[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2017 , 37(3) : 403 . DOI: 10.3969/j.issn.1674-8115.2017.03.025
/
| 〈 |
|
〉 |